However, the XRCC1 rs25487 A allele was associated with a bad survival outcome for advanced NSCLC patients, and these effects were mainly seen in male patients, and in patients who underwent chemotherapy but without surgery and radiotherapy. Here, XRCC1 is linked to non-small cell lung carcinoma.